![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Gynesonics’ Sonata System 2.1 Gets Green Light
Gynesonics’ Sonata System 2.1 Gets Green Light
Gynesonics has earned 510(k) clearance from the FDA for its next-generation Sonata System 2.1 for ablating symptomatic uterine fibroids.
The platform combines ultrasound with an advanced radio-frequency ablation device, allowing for incisionless, transcervical treatment of fibroids in the uterus.
The new version of the Sonata system includes a smaller, more efficient radio-frequency ablation handpiece with improved controls.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct